Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | chromobox protein, putative | 0.0123 | 0.0712 | 0.225 |
Trichomonas vaginalis | chromobox protein, putative | 0.0096 | 0.0462 | 0.1182 |
Trypanosoma cruzi | Replication factor A protein 1 | 0.0153 | 0.0985 | 0.5 |
Trichomonas vaginalis | chromobox protein, putative | 0.0123 | 0.0712 | 0.225 |
Giardia lamblia | Hypothetical protein | 0.0047 | 0 | 0.5 |
Onchocerca volvulus | Putative replication factor A 73 kDa subunit | 0.0285 | 0.2215 | 1 |
Toxoplasma gondii | OB-fold nucleic acid binding domain-containing protein | 0.008 | 0.0311 | 0.1564 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0094 | 0.0436 | 0.1231 |
Schistosoma mansoni | chromobox protein | 0.0963 | 0.8501 | 1 |
Loa Loa (eye worm) | helicase | 0.0067 | 0.0186 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0228 | 0.1684 | 0.6435 |
Brugia malayi | Associated with TFs and helicases family protein | 0.0067 | 0.0186 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Entamoeba histolytica | replication factor A protein 1, putative | 0.0137 | 0.084 | 1 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.0319 | 0.2526 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Leishmania major | replication factor A, 51kDa subunit, putative | 0.0153 | 0.0985 | 0.5 |
Brugia malayi | Heterochromatin protein 1 | 0.0123 | 0.0712 | 0.2319 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.0319 | 0.2526 | 1 |
Echinococcus multilocularis | replication protein A 70 kDa DNA binding | 0.0319 | 0.2526 | 0.2385 |
Brugia malayi | M-phase phosphoprotein, mpp8 | 0.0067 | 0.0186 | 0.0088 |
Brugia malayi | Valyl-tRNA synthetase | 0.0067 | 0.0186 | 0.0088 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.0153 | 0.0985 | 0.3418 |
Loa Loa (eye worm) | replication factor A 73 kDa subunit | 0.0319 | 0.2526 | 1 |
Schistosoma mansoni | chromobox protein | 0.0123 | 0.0712 | 0.0633 |
Echinococcus multilocularis | chromobox protein 1 | 0.0123 | 0.0712 | 0.0537 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0.0436 | 0.1068 |
Plasmodium vivax | replication protein A1, large subunit, putative | 0.0153 | 0.0985 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0096 | 0.0462 | 0.1182 |
Loa Loa (eye worm) | CHromoDomain protein family member | 0.0067 | 0.0186 | 0.0088 |
Brugia malayi | chromobox protein homolog 3 | 0.0094 | 0.0436 | 0.1147 |
Brugia malayi | Type III restriction enzyme, res subunit family protein | 0.0067 | 0.0186 | 0.0088 |
Brugia malayi | replication factor A 73 kDa subunit | 0.0319 | 0.2526 | 1 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0096 | 0.0462 | 0.1363 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0.0436 | 0.1068 |
Trypanosoma brucei | Replication factor A protein 1 | 0.0153 | 0.0985 | 0.5 |
Brugia malayi | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Brugia malayi | SET domain containing protein | 0.0067 | 0.0186 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.0436 | 0.1147 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0905 | 0.3137 |
Echinococcus multilocularis | chromobox protein 2 | 0.1124 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0905 | 0.3137 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0905 | 0.3137 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Brugia malayi | Protein cec-1. | 0.0228 | 0.1684 | 0.6435 |
Echinococcus multilocularis | chromobox protein 1 | 0.0123 | 0.0712 | 0.0537 |
Echinococcus granulosus | chromobox protein 1 | 0.0123 | 0.0712 | 0.0537 |
Trichomonas vaginalis | replication factor A 1, rfa1, putative | 0.0303 | 0.238 | 0.9377 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0123 | 0.0712 | 0.2319 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.0186 | 0.0088 |
Plasmodium falciparum | replication protein A1, large subunit | 0.0153 | 0.0985 | 1 |
Schistosoma mansoni | replication factor A 1 rfa1 | 0.0319 | 0.2526 | 0.2814 |
Schistosoma mansoni | chromobox protein | 0.0123 | 0.0712 | 0.0633 |
Toxoplasma gondii | replication factor-a protein 1 (rpa1) subfamily protein | 0.0153 | 0.0985 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0123 | 0.0712 | 0.0537 |
Echinococcus granulosus | replication protein A 70 kDa DNA binding | 0.0319 | 0.2526 | 0.2385 |
Brugia malayi | CHD4 protein | 0.0067 | 0.0186 | 0.0088 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.8913 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.